Home > Innovation > Technology Offer/Portfolio

Technology Offer/Portfolio

Highlighted patents

Novel CDK8 kinase inhibitors for the treatment of cancer.
Ref. CNIO-13002
Pastor J, et al. Macrocyclic compounds and their use as CDK8 inhibitors.
WO 2013/001310.

PI3K Kinase inhibitor for use in the treatment of obesity.
Ref. CNIO-13003
Pastor J, et al. Use of PI3K inhibitors for the treatment of obesity, steatosis and ageing. WO2012/052730.

Antibodies catalogue

View our Monoclonal Antibodies Catalogue

To find out more information about our patent and technology portfolio available for licensing and collaborations please contact